Related Experiment Video
Updated: Mar 5, 2026

04:24
A Mouse Distraction Osteogenesis Model
Published on: November 14, 2018
6.8K
MiR-503 Promotes Bone Formation in Distraction Osteogenesis through Suppressing Smurf1 Expression
Yuxin Sun1,2,3, Jia Xu4, Liangliang Xu2,3
1Department of Orthopaedics and Traumatology, Bao-An District People's Hospital, Shenzhen, P.R. China.
Scientific Reports
|March 26, 2017
Summary
MicroRNA-503 (miR-503) promotes bone formation during distraction osteogenesis (DO) by downregulating Smurf1. This discovery offers a potential new therapeutic target for enhancing bone repair.
Area of Science:
- Molecular Biology
- Regenerative Medicine
- Orthopedic Surgery
Background:
- Distraction osteogenesis (DO) is a clinical technique for bone regeneration, but its molecular mechanisms are not fully understood.
- MicroRNAs (miRNAs) are epigenetic regulators known to influence osteogenesis, making them potential targets for understanding DO.
Purpose of the Study:
- To identify key microRNAs involved in the molecular mechanisms of distraction osteogenesis.
- To investigate the role of miR-503 in promoting osteogenesis and bone formation in a rat DO model.
Main Methods:
- Established a rat model for distraction osteogenesis.
- Utilized microRNA microarray analysis to identify differentially expressed miRNAs.
- Performed in vitro and in vivo experiments, including gene knockdown and antagomir treatment, coupled with bioinformatic and luciferase assays.
Main Results:
- Identified 100 differentially expressed miRNAs in DO, with miR-503 significantly upregulated.
- Overexpression of miR-503 promoted osteogenesis in vitro and accelerated mineralization in vivo.
- Demonstrated that miR-503 directly targets and suppresses Smurf1, a negative regulator of osteogenesis.
Conclusions:
- miR-503 acts as a positive regulator of osteogenesis and bone formation during distraction osteogenesis.
- The miR-503/Smurf1 pathway is a critical mechanism mediating osteogenic differentiation.
- miR-503 represents a promising therapeutic target for enhancing bone repair strategies.

